In this on-demand webinar for pharmacists, hear from a panel leading Australian pharmacists as they discuss their views and insights around the use of biosimilar medicines
By the end of this course, participants should be able to:
- Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
- Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product
- Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system.
This activity has been accredited for 1.0 hour of Group 1 CPD (or 1 CPD credits) suitable for inclusion in an individual pharmacist’s CPD plan.
Other healthcare professionals can still enrol and complete this course. You will receive a certificate upon completion.